IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29,505 | +49.9% | 750 | -7.3% | 0.00% | – |
| Q1 2023 | $19,683 | -48.1% | 809 | -54.3% | 0.00% | – |
| Q4 2022 | $37,939 | -91.7% | 1,772 | -93.0% | 0.00% | -100.0% |
| Q3 2022 | $457,000 | +22750.0% | 25,445 | +15510.4% | 0.00% | – |
| Q2 2022 | $2,000 | -88.9% | 163 | -85.1% | 0.00% | – |
| Q1 2022 | $18,000 | +5.9% | 1,094 | +7.7% | 0.00% | – |
| Q4 2021 | $17,000 | 0.0% | 1,016 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | +240.0% | 1,016 | +33.5% | 0.00% | – |
| Q2 2021 | $5,000 | – | 761 | +1629.5% | 0.00% | – |
| Q1 2021 | $0 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |
| PRECEPT MANAGEMENT LLC | 130,000 | $5,114,200 | 6.94% |